BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 32180300)

  • 1. Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients.
    Lombardi A; Vitale V; Nigri G; Olivieri C; Mastrangeli MR; Bizzaglia E; Amanti C
    Breast J; 2020 Jul; 26(7):1265-1269. PubMed ID: 32180300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
    Xu L; Li JH; Ye JM; Duan XN; Cheng YJ; Xin L; Liu Q; Zhou B; Liu YH
    Chin Med J (Engl); 2017 Aug; 130(16):1945-1952. PubMed ID: 28776547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging System in HER2-Enriched Subtype Breast Cancer, a Retrospective Analysis.
    Zhou B; Xu L; Ye J; Xin L; Duan X; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4615-4621. PubMed ID: 28739761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the pathological prognostic staging system proposed in the revised eighth edition of the AJCC staging manual in different molecular subtypes of breast cancer.
    Jang N; Choi JE; Kang SH; Bae YK
    Virchows Arch; 2019 Feb; 474(2):193-200. PubMed ID: 30474738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The 8th edition of the American Joint Committee on Cancer staging system provide improved prognostic accuracy in T1-2N1M0 postmastectomy breast cancer patients].
    Sun GY; Wang SL; Tang Y; Yang Y; Fang H; Wang JY; Jing H; Zhang JH; Jin J; Song YW; Liu YP; Chen B; Qi SN; Li N; Tang Y; Lu NN; Wang WH; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):615-623. PubMed ID: 31434454
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
    Tang L; Ishikawa Y; Matsushita H; Jingu K
    Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
    Lee SB; Sohn G; Kim J; Chung IY; Lee JW; Kim HJ; Ko BS; Son BH; Ahn SH
    Breast Cancer Res Treat; 2018 Jun; 169(2):257-266. PubMed ID: 29388016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
    Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective prognostic evaluation analysis using the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system for luminal A breast cancer.
    Ye J; Wang W; Xu L; Duan X; Cheng Y; Xin L; Zhang H; Zhang S; Li T; Liu Y
    Chin J Cancer Res; 2017 Aug; 29(4):351-360. PubMed ID: 28947867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system in triple-negative breast cancer.
    Li JP; Zhang XM; Zhang YS; Zheng LH; Liu YJ
    Neoplasma; 2019 Sep; 66(5):810-817. PubMed ID: 31129969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
    Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
    BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.
    Mittendorf EA; Ballman KV; McCall LM; Yi M; Sahin AA; Bedrosian I; Hansen N; Gabram S; Hurd T; Giuliano AE; Hunt KK
    J Clin Oncol; 2015 Apr; 33(10):1119-27. PubMed ID: 25488970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution.
    Tokunaga E; Ijichi H; Tajiri W; Masuda T; Takizawa K; Ueo H; Koga C; Tanaka J; Nakamura Y; Ohno S; Taguchi K; Okamoto M
    Breast Cancer; 2020 Nov; 27(6):1137-1146. PubMed ID: 32472474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort.
    Kim JY; Lim JE; Jung HH; Cho SY; Cho EY; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
    Breast Cancer Res Treat; 2018 Oct; 171(3):737-745. PubMed ID: 29931426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.
    Shao N; Xie C; Shi Y; Ye R; Long J; Shi H; Shan Z; Thompson AM; Lin Y
    Cancer Manag Res; 2019; 11():1433-1442. PubMed ID: 30863154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
    Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
    Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making.
    Lian CL; Li GQ; Zhou P; Wang J; He ZY; Wu SG
    Breast; 2021 Oct; 59():117-123. PubMed ID: 34229126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the American Joint Committee on Cancer 8th edition staging system for the pancreatic ductal adenocarcinoma.
    Shin DW; Lee JC; Kim J; Woo SM; Lee WJ; Han SS; Park SJ; Choi KS; Cha HS; Yoon YS; Han HS; Hong EK; Hwang JH
    Eur J Surg Oncol; 2019 Nov; 45(11):2159-2165. PubMed ID: 31202572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.